Clinical Trials Directory

Trials / Completed

CompletedNCT02722980

Efficacy of a Probiotic Product on Bone Mineral Density (BMD) in Healthy Women in Early Post-menopausal Phase

A Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical Study Aiming to Evaluate the Efficacy on BMD and Safety of a Probiotic Product in a Population of Healthy Women in Early Post-menopausal Phase, During an Intervention Period of 12 Months

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
249 (actual)
Sponsor
Probi AB · Industry
Sex
Female
Age
45 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim of the current study is to evaluate the efficacy of a probiotic product on bone mineral density (BMD) in healthy early post-menopausal women, compared to placebo. The primary endpoint is to assess changes of BMD at lumbar spine after an intervention period of 12 months. Changes in BMD at the femoral neck (hip) will also be measured as well as changes in bone turnover markers during the period of 12 months.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlaceboThe intervention consists of capsules containing placebo.
DIETARY_SUPPLEMENT: Probiotic capsulesThe intervention consists of capsules containing probiotics.

Timeline

Start date
2016-04-01
Primary completion
2018-01-01
Completion
2018-01-01
First posted
2016-03-30
Last updated
2018-04-17

Locations

2 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT02722980. Inclusion in this directory is not an endorsement.